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Occupational Lymphohematopoietic Cancer in Korea 
The purpose of this study was to review the existing studies on lymphohematopoietic (LHP) 
cancer in Korea, estimate the prevalence of workers exposed to carcinogens, and determine 
the population attributable fraction (PAF) of leukemia. Two case series and 4 case reports 
were reviewed. Using official statistics, the prevalence of benzene exposure and ionizing 
radiation exposure was estimated. Based on the prevalence of exposure and the relative 
risk, The PAF of leukemia was calculated. Between 1996 and 2005, 51 cases of LHP cancer 
were reported from the compensation system. Greater than 50% of occupational LHP 
cancer was leukemia, and the most important cause was benzene. In a cohort study, the 
standardized incidence ratio was 2.71 (95% CI, 0.56–7.91). The prevalence of exposure was 
2.5% and 2.2% in 1995 and 2000, respectively. Using the 1995 prevalence, 3.6-4.8% and 
0.1% of cases with leukemia were attributable to benzene and ionizing radiation exposure, 
respectively, which resulted in 39.7-51.4 cases per year. Benzene is the most important 
cause of occupational leukemia in Korea. Considering the estimated PAF in this study, the 
annual number of occupational LHP cancer (51 cases during 10-yr period), might be under-
reported within the compensation system.
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INTRODUCTION
Lymphohematopoietic (LHP) cancers are amongst the most 
common work-related malignancies (1). The International Agen-
cy for Research on Cancer (IARC) (2) has strong evidence that 
exposure to benzene, ethylene oxide, 1,3-butadiene, ionizing 
radiation, and boot and shoe manufacturing and repair signifi-
cantly increases the risk for developing leukemia and non-Hodg-
kin lymphoma. 
  Following the industrialization of Korea since 1960, the pet-
rochemical manufacturing industry expanded between 1970 
and 1980 (3). Expenditures for benzene and 1,3-butadiene in-
creased and reached 3.9 and 0.9 million tons, respectively, by 
1998 (4). Ionizing radiation was introduced in 1978 in nuclear 
power plants and workplaces using non-destructive instruments. 
Medical professionals using radiography-generating devices 
existed in Korea before 1970 (5). Official records of occupation-
al-related LHP cancer during 1960-1980 are not available; how-
ever, two cases of aplastic anemia in workers exposed to ben-
zene have been reported in historical records (6). 
  Official statistics for occupational-related cancers in Korea 
relies on reporting from the Korea Workers Compensation and 
Welfare Service (COMWEL), which has been in existence since 
1992. Workers’ compensation reports of LHP cancers, especially 
leukemia and non-Hodgkin’s lymphoma, are the second most 
common occupational-related cancers in Korea (7-15), as based 
on an epidemiologic investigation by the Occupational Safety 
and Health Research Institute (OSHRI) of the Korea Occupa-
tional Safety and Health Agency (KOSHA). Annual compensa-
tion for LHP cancers has been reported in less than 10 cases (7, 
11); however, these investigations were related to compensa-
tion issues, and the results do not reflect the total occurrence of 
occupation-related LHP cancers in Korea. 
  The global attributed fraction of occupational-related leuke-
mia, reported in a project conducted by the World Health Orga-
nization (WHO), is 2% of the population attributable fraction 
(PAF) (1). Similarly, an estimate of the number of Korean work-
ers affected was attempted by Cho et al. (16), who reported that 
0.8% of leukemias were attributable to occupational exposure 
(16). A total of 2,289 cases of leukemia were registered in the 
Central National Cancer Registry of Korea in 2005 (17); howev-
er, according to the estimation by Driscoll et al. (1), more than 
45 cases of leukemia per year might be attributed to occupation-
al exposure. These estimates are proportional, and therefore 
dependent on the prevalence of occupational and other carci-
nogenic risk factors in a population.
  To reveal the detailed features of occupational LHP cancers 
in Korean workers, several studies on this topic have been con-
ducted which have reported the relative risk of benzene and 
ionizing radiation exposure in Korean workers, and provided 
useful information on prevalence of these cancers in Korean 
workers (3, 14, 15, 18).   Kim E-A, et al.  •  Occupational Lymphohematopoietic Cancer in Korea 
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  The purpose of this study was to review the reported cases of 
occupational-related LHP and studies on LHP cancers in Korea. 
We also estimated the prevalence of risk factors regarding occu-
pational-related LHP cancers in Korean workers using official 
statistics (19). With the estimated prevalence, we calculated the 
PAF of leukemia in Korea and compared this data with the PAF 
of leukemia from other reports using Levin’s formula (20).
MATERIALS AND METHODS
Review of published studies
The authors reviewed previously published cases of occupation-
al-related LHP cancer. Cases of LHP cancer from the workers’ 
compensation system have been reported in two studies. Kang 
et al. (7) analyzed cancer cases, including reports of 10 LHP can-
cers which had been investigated by OSHRI/KOSHA during 
1992-2000, included in the data from COMWEL that accounts 
for related occupational diseases. Ahn (11) analyzed all com-
pensated LHP cases between 1996 and 2005 from the COMW-
EL data. 
  In reviewing studies on occupational carcinogenic factors 
and cancers in Korean workers, the authors selected 4 articles 
which had been conducted since 2006. A study on occupation-
related LHP cancers and benzene exposure was conducted in 
Korea (18). A cohort study involving benzene- and 1,3-butadi-
ene-exposed workers reported in 2010 from the petrochemical 
industry focused on highly exposed groups (3). Another cohort 
study involving iron steel workers also reported LHP cancer 
morbidity which was apparently related to benzene exposure 
(15). Lastly, a study focused on radiation-exposed workers in 
Korea in 2008 (14). One of these reviewed studies reported the 
estimation of the PAF in Korea (16).
Estimation of the prevalence of exposure 
The prevalence of exposure of carcinogenic LHP cancers was 
estimated in workers exposed to benzene and ionizing radia-
tion. The prevalence was used for calculating the PAF of LHP 
cancers among total cancer mortality and incidence in 2005. 
Considering the 5-10 yr latent period for LHP cancers (21) relat-
ed to benzene or ionizing radiation exposure, we estimated the 
prevalence of exposure in the population for 1995 and 2000.  
Benzene-exposed workers were estimated based on the national 
survey of mining and manufacturing industries from the Kore-
an Statistical Information Service (KSIS) (19). Benzene has been 
reported to be used in the petrochemical, shoe-making, and 
painting-related industries, thus we determined the number of 
workers in those industries from the KSIS system. 
  Because of a lack of information, 1,3-butadiene-exposed work-
ers were not included in this estimation of the prevalence. How-
ever, the major proportion of 1,3-butadiene was produced in 
the petrochemical industry, therefore most 1,3-butadiene ex-
posures were included in the benzene-exposed workers.     
  Ionizing radiation exposures have occurred in special indus-
tries, and are strictly controlled by government organizations. 
The ionizing radiation-exposed population has been estimated 
based on the number of radioisotopes used in industries from 
the statistics of the Korea Radioisotope Association (5) and mul-
tiplying by the average number of workers. 
  According to KSIS, the economically-active population count 
in Korea in 1995 was 20.85 million (22). The survey from KSIS 
was conducted on workers employed in manufacturing and 
mining industries, which totaled 4.5 million. Notably excluded 
were the workers in other industries and unemployed workers.
  To adjust for this bias, the authors adopted the following pro-
cess, according to the IARC report on causes of cancers in France 
(23).
  Step 1: The exposed proportion of workers for each carcino-
gen using the denominator was used according to 
the source of the information of the each carcinogen.
  Step 2: The industries other than manufacturing or mining 
included 13.7 million workers. This population was 
susceptible to exposure, but at a much lower level 
than workers in manufacturing or mining. One-fourth 
of the prevalence estimated in Step 1 was applied to 
this population.
  Step 3: Unemployed workers among the economically-ac-
tive population numbered 2.9 million. Because this 
population could have been exposed during a previ-
ous occupation before the unemployed period, we 
considered that unemployed workers had an occu-
pational prevalence of exposure equal to one-fourth 
of the prevalence estimated in Step 1.
  Step 4: The population of individuals more than 65 yr of age 
(2.6 million) might have past exposures which could 
be higher than present levels, accounting for the de-
crease in exposure from occupational carcinogens. 
We applied a correction factor of 1.25 to the preva-
lence of occupational exposure computed for the 
overall economically-active population (Steps 1-3). 
  Step 5: The prevalence from Step 1 was derived from cross-
sectional studies, which is based only on the last job 
held. Hence, for the estimation of lifetime occupa-
tional prevalence of exposure, a factor of 4 was ap-
plied. This was based on the report involving the 
lifetime turnover rate from the Korea Employment 
Information System (24). 
Calculation of the PAF
The relative risk (RR) reported the IARC, which was adopted in 
the report demonstrating PAF analysis (23), was reviewed. Stud-
ies on the RR of occupation-related leukemia from Korean work-
ers exposed to benzene (3, 18) and radiation (14) were also re-Kim E-A, et al.  •  Occupational Lymphohematopoietic Cancer in Korea 
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viewed. A RR of 3.3 for leukemia from benzene exposure was 
calculated from the IARC report (23), and 2.7 was calculated 
from the Korean workers report (3). A RR for leukemia from 
ionizing radiation was calculated to be 1.22 from the combined 
analysis of the studies from the USA, UK, and Canada (25), and 
0.59 from the Korean workers report (14). 
  The PAF was calculated (vide infra) as the function of the RR 
and the prevalence of exposure, as described by Levin (20). 
              PAF=P×(RR-1)/[P×(RR-1)+1] 
              P: prevalence of the workers exposed to a carcinogen
              RR: relative risk
  The annual reports from the National Cancer Center of Korea 
and KOSIS were used to calculate the mortality of leukemia (n= 
670) (22) and the incidence (n=1,063) (17) of leukemia among 
persons aged from 15-60 yr in 2005. 
RESULTS
Case reports and case series 
Baak et al. (13) reported a case of aplastic anemia from the pet-
rochemical industry in 1999. The workers were in a petroleum 
resin-producing factory and had been exposed to a low-level of 
benzene while packaging the powder resin and pouring lime 
into a deactivation tank. The airborne benzene level was approx-
imately 0.28 ppm. 
  Kang et al. (7) reported 34 cases of LHP cancers investigated 
by OSHRI/KOSHA between 1992 and 2000. After the investiga-
tion, 10 of 34 cases were found to be work-related cases (Table 1). 
There were 3 cases of acute myeloid leukemia, 4 cases of myelo-
dysplastic syndrome, 1 case of myelofibrosis, 1 case of non-Hodg-
kin’s lymphoma, and 1 case of multiple myeloma. All of the cases 
were male workers (32-58 yr of age). Four cases of LHP cancers 
were determined not to be work-related based on the investiga-
tion by OSHRI/KOSHA. All cases, but one, were shown to be 
benzene-related cancers. The length of employment was be-
tween 4 and 21 yr (Table 1).
  Ahn (11) reviewed 51 cases of LHP cancers, which had been 
accepted for payment by COMWEL during 1996-2005 (Table 2). 
The most common LHP cancer was myeloid leukemia, which 
occurred in 21 among 51 cases. Lymphoid leukemia and aplas-
tic anemia were shown in 7 cases. Other cancers included non-
Hodgkin’s lymphoma (n=6), myelodysplastic syndrome (n=4), 
multiple myeloma (n=2), and others (n=3). All but 3 cases in-
Table 1. Lymphohematopoietic cancer cases from reports by of OSHRI/KOSHA between 1992 and 2000 reported by Kang et al. (7)
Year* Disease
Age at  
diagnosis (yr)
Working  
duration (yr)
Industry Job Cause
1994
† Acute myeloid leukemia  36   6 Car manufacturing Painting Benzene
1995
† Acute myeloid leukemia 41 21 Communication service Maintenance Benzene
1997
† Acute myeloid leukemia 43 11 Car manufacturing Maintenance Benzene
1997 Myelodysplastic syndrome 44 19 Tire manufacturing Solvent using Benzene
1998 Myelodysplastic syndrome 51 13 Tire manufacturing Various Benzene
1998 Multiple myeloma 48 17 Machine manufacturing Molding Benzene
1999 Myelofibrosis 33   4 Research institute Researcher Benzene
1999 Myelodysplastic syndrome 58   6 Car maintenance Painting Benzene
2000 Myelodysplastic syndrome 32 16 Machine manufacturing Researcher Benzene
2000 Acute myeloid leukemia 37 12 Nuclear power plant Welding Radiation
2000 Acute myeloid leukemia 54 15 Car manufacturing Painting Benzene
2000 Acute myeloid leukemia 49 25 Cokes production Various Benzene
2000 Non-Hodgkin’s syndrome 45 20 Cokes production Various Benzene
2000** Aplastic anemia 35   8 Leather manufacturing Various Benzene
*: year of report by; OSHRI, Occupational Safety and Health Research Institute; KOSHA, Korea Occupational Safety and Health Agency; 
†: Cases were deemed not work-related 
exposures in the investigation by OSHIRI/KOSHA, but compensated through administrative litigation.
Table 2. Compensated cases of lymphohematopoietic cancers by COMWEL between 
1996 and 2005 reported by Ahn (11)
No. of cases (%)
Kinds of diseases
   Myeloid leukemia
   Lymphoid leukemia
   Aplastic anemia
   Non-Hodgkin’s lymphoma
   Myelodysplastic syndrome
   Multiple myeloma
   Others
21 (42.0)
  7 (14.0)
  7 (14.0)
  6 (12.0)
4 (8.0)
2 (4.0)
3 (6.0)
Gender
   Male
   Female
47 (94.0)
3 (6.0)
Causative agents
   Benzene
       Pure benzene
       Impurity in a mixture
14 (27.5)
29 (56.9)
   Ionizing radiation 4 (8.0)
   Others 3 (6.0)
   Latency period (yr)
       -4.9
       5.0-9.9
       10.0-19.9
       20.0-
       Mean (yr)
4 (8.0)
  9 (18.0)
22 (44.0)
15 (30.0)
15.1±7.6
Total   28 (11.8%)
COMWEL, Korea Workers Compensation and Welfare Service.Kim E-A, et al.  •  Occupational Lymphohematopoietic Cancer in Korea 
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volved male workers. The most common causative agent of com-
pensated LHP cancers was benzene (n=43). Among the 43 ben-
zene exposure cases, 14 were shown to be due to pure benzene 
exposure. Others were exposed to benzene through an impuri-
ty in mixtures, such as cement, solvent, cleaning agents, and 
hardener. The records of exposure for benzene were available 
in 16 of the cases, which ranged from 0.08-6.54 ppm. Ionizing 
radiation exposure cases were determined in four workers (a 
radiologist in a hospital, a radiation safety manager at a univer-
sity, a welder in a nuclear power plant, and a technician in a ra-
diation apparatus manufacturer). The amount of radiation ex-
posure from 3 of the cases was 0.49, 19.9 and 31.8 mSv. The mean 
latency was 15.5 yr (16.1 yr for benzene and 9.5 yr for ionizing 
radiation).   
 
Cohort studies 
The first attempt for a cohort study on occupation-related can-
cers in the Korean working population was conducted by Ahn  
(18) (Table 3). This cohort involved recruiting workers who re-
ceived workers’ medical monitoring for occupational exposure 
to carcinogens, including benzene. The cohort included 24,279 
workers who received medical monitoring from 2000-2004. 
Among the total cohort, 16,288 workers were exposed to ben-
zene. To calculate the standardized rate ratio (SRR), an internal 
comparison group was selected from the workers who were not 
exposed to benzene in the cohort. The SRR was 0.38 (range, 0.05–
3.10) for the incidence of LHP cancer, and 1.82 (range, 0.51-6.5) 
for LHP cancer admissions. 
  Another cohort study on benzene- and 1,3-butadiene-ex-
posed workers was conducted at the petrochemical complex 
located in the southern part of Korea (Yeosu and Kwangyang 
regions; Table 3) (3). This cohort consisted of 43,000 workers, 
temporary construction workers who were supposedly exposed 
to the highest levels of benzene. During the benzene manufac-
turing process in the petrochemical industries, the construction 
workers did the maintenance work of connecting, disconnect-
ing, evacuating, and cleaning the various vessels and pipes. Dur-
ing these processes, which were referred to as the ‘shut down’ 
process, the workers were exposed to benzene levels of up to 
hundreds of ppm. The standardized mortality ratio (SMR) was 
1.46 (95% CI, 0.39–2.78) for leukemia and 1.24 (95% CI, 0.15–
4.47) for non-Hodgkin’s lymphoma. The standardized incidence 
ratio (SIR) was 2.71 (95% CI, 0.56–7.91) for leukemia and 1.83 
(95% CI, 0.38-5.34) for non-Hodgkin’s lymphoma.
  In the iron and steel industry, workers are potentially exposed 
to a number of carcinogens, including benzene. A cohort study 
of the iron and steel industry reported the LHP cancer morbidity 
(Table 3) (15). Work histories were merged with the national can-
cer registry for 44,974 workers who were followed from 1988-2001. 
Based on the results, the incidence of LHP cancer compared to 
that of office and production workers was higher in the coke pro-
duction process in the plants (SRR, 3.46; 95% CI, 1.02-8.91). 
  Cancer mortality and morbidity in Korean workers exposed 
to ionizing radiation was described for the first time in 2008 
(Table 3) (14). The mean cumulative exposure dose of radiation 
was 6.4 mSv. A majority of the study population (68.9%) had been 
exposed to 0.01-9.99 mSv; however, only 2.5% of them were ex-
posed to more than 50 mSv. The SMR for leukemia and non-
Hodgkin’s lymphoma was 0.59 (95% CI, 0.28-1.06) and 1.26 (95% 
CI, 0.63-2.22), respectively.
Table 3. Cohort studies from Korea on lymphohematopoietic cancer risks
Author (reference) Industry Causative agents Observation period  Person-year  Risk ratio for LHP cancers
Ahn (18)  Various Benzene 2000-2006   70,973 SRR for LHP incidence: 0.38 (0.05-3.10) 
SRR for LHP admission: 1.82 (0.51-6.5)
Koh (3) Petrochemical Benzene and 
1,3-butadiene
1988-2005 100,300 SMR for leukemia: 1.46 (0.39-2.78)
SIR for leukemia: 2.71 (0.56-7.91)
SMR for NHL: 1.24 (0.15-4.47)
SIR for NHL: 1.83 (0.38-5.34)
Ahn et al. (15) Foundry Benzene 1988-2001   43,869 SRR for LHP mortality: 3.46 (1.02-8.91) 
Ahn et al. (14) Various Ionizing radiation 1992-2004 633,159 SMR for leukemia: 0.59 (0.28-1.06)
SMR for LHP: 1.26 (0.63-2.22)
LHP, lymphohematopoietic cancers; SMR, standardized mortality ratio; SIR, standardized incidence ratio; SRR, standardized rate ratio; NHL, non-Hodgkin’s lymphoma.
Table 4. Prevalence of exposure for workers exposed to lymphohematopoietic carcinogens
Industry
Number of workers* Prevalence (%)
†
1995 2000 1995 2000
Ionizing radiation   31,920   50,760 0.36 0.57
Benzene             Shoe manufacturer
           Painting & printing
           Petrochemical
  44,199
  31,148
  23,407
  25,287
  35,277
  13,725
0.97
0.68
0.51
0.56
0.78
0.30
130,674 125,049 2.51 2.21
*Numbers derived from Korea Statistical Information System and Korea Radioisotope Association; 
†Estimated prevalence of lifetime exposure among the total Korean population.   Kim E-A, et al.  •  Occupational Lymphohematopoietic Cancer in Korea 
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Prevalence of exposure and the PAF
The major industries related to benzene exposure are shoe mak-
ing, painting, and printing and petrochemicals (Table 4). The 
number of workers exposed to benzene and ionizing radiation 
were 130,674 in 1995 and 125,049 in 2000. Compared to 1995, 
the number of petrochemicals and shoe manufacturers was 
decreased, while the painting, printing, and ionizing radiation 
industries increased in number in 2000.
  After applying the correction process, as described in the 
Methods section, the prevalence of benzene- and ionizing radi-
ation-exposed workers was 2.51% and 2.21% in 1995 and 2000, 
respectively.
  Using the 1995 prevalence of exposure, 4.8% of leukemias 
were attributable to benzene and 0.1% to radiation (Table 5). 
Using the prevalence from 2000, the PAF was lower than that 
based on the prevalence in 1995. Because the Korean RR of ra-
diation exposure was less than 1, the PAF based on the RR of 
Korean workers was lower than the PAF based on the IARC.
DISCUSSION 
Greater than 50% of the reported occupational LHP cancers 
have been leukemia and lymphoma since 1996 (Tables 1, 2). 
Most of the reported LHP cancers in this review were related to 
compensation issues. The compensation of diseases from oc-
cupational exposure has been based on the public insurance 
system since 1963 and the premium should be paid by the em-
ployer. Therefore, the compensated cancers could not represent 
the total number of occupational LHP cancers in Korea.  
  The decision-making process for compensation at COMWEL, 
especially on the topic of cancers from occupational exposure, 
largely depends on the epidemiologic investigations of OSHRI/
KOSHA. Due to the lack of professional investigation proficiency, 
COMWEL requested a scientific decision on the work-related-
ness of the cancer cases from OSHRI/KOSHA since 1992 (Table 
1). Through cooperation between COMWEL and OSHRI, the 
decision regarding the work-relatedness of LHP cancers was 
reasonably accurate.  
  The major etiologic agents of occupational LHP cancer in 
this review were restricted to benzene and ionizing radiation 
(Table 2). Although 1,3-butadiene and ethylene oxide are listed 
Table 5. Population attributed fraction (PAF) of leukemia
Year* Risk factors
RR PAF (%) Number of Incidence
†  Number of deaths
†
IARC Korea a b a b a b
1995 Benzene
Radiation
3.3
  1.22
2.7
0.6
4.8
0.1
  3.6
-0.1
50.6
  0.8
37.8
-1.5
31.9
  0.5
23.8
-1.0
2000 Benzene
Radiation
3.3
  1.22
2.7
0.6
3.6
0.1
  2.7
-0.2
38.4
  1.3
28.7
-2.4
24.2
  0.8
18.1
-1.5
*year of exposure prevalence; 
†estimated number based on the PAF and the national statistics of cancer in 2005; a, estimated value adopting the RR of IARC; b, estimated value 
adopting the RR of Korea.
RR, relative risk; IARC, International Agency for Research on Cancer; PAF, population attributable fraction.
as IARC group 1 carcinogens, the exposure assessment for those 
agents in Korea is conducted very irregularly. 
  The most common causative agents of compensated LHP 
cancers were due to benzene exposure (83%). According to the 
investigation of the individual cases (11), only 14 cases, mainly 
from the petrochemical industry, of the 43 benzene exposure 
cases were related to pure benzene exposure. Other cases were 
found because of exposure to benzene as an impurity in mix-
tures and the levels of exposure for benzene were relatively low 
(<1 ppm).
  The levels of benzene exposure in Korea have decreased con-
tinuously. The Occupational Exposure Level (OEL) in Korea for 
benzene was 25 ppm until 1970, according to the Occupational 
Safety and Health Act of Korea. With this Act, there was enforce-
ment of regulations for worker’s safety and health by the Minis-
try of Employment and Labor; the OEL was 10 ppm until 2003. 
The average level of exposure of benzene in the leather and 
chemical product industries was 2–23 ppm, with a wide range 
of 0.1-56.9 (26). After 2003, the OEL of benzene was lowered to 
1 ppm. As a result of this, the average airborne concentration of 
benzene in most industries was less than 1 ppm, except for the 
temporary workers in the petrochemical plants (3). 
  Only 51 cases of LHP during a span of 10 yr were compensat-
ed in Korea, which seems to be low compared to Germany, where 
153 leukemia cases were compensated between 1991 and 1994 
(27). However in Italy, only 10 cases of leukemia (28) were com-
pensated between 1989 and 1994, which is similar with Korea. 
  Using 1995 prevalence of exposure levels, 3.6-4.8% of leuke-
mia were expected to be attributable to benzene exposure and 
0.1% for radiation exposure (Table 5). Therefore, annually 39.7-
51.4 cases of leukemia are supposed to be caused by workplace 
exposures. Thus, there might be more workers that are lost in 
the compensation system.   
  Using the prevalence levels of 2000, the PAFs were lower than 
those using 1995 prevalence levels. Based on the level of expo-
sure of major carcinogenic factors, benzene exposure was de-
creased after 2000, and the PAF using the 2000 exposure preva-
lence was lower than the PAFs using the 1995 prevalence. 
  The PAF of leukemia in this study was similar to the reported 
levels from France in 2000 (4.1%) (23). The possibility of under-
estimation in this study with carcinogens was restricted to ion-Kim E-A, et al.  •  Occupational Lymphohematopoietic Cancer in Korea 
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izing radiation and benzene exposure. The 1,3-butadiene and 
ethylene oxide were confirmed carcinogens by IARC and the 
LHP cancers attributed to occupational exposure might be high-
er if the information from these carcinogens was included. 
  In conclusion, leukemias related to benzene exposure are the 
most important diseases which are attributed to occupational 
exposure. Although the compensated cases are less than 10 cas-
es per year, according to the estimated PAF for leukemias in this 
study, the annual cases of occupation-related leukemia are cal-
culated to be between 39.7 and 51.4 cases, which implies an 
under-reporting in the compensation system. Several studies 
for occupation-based LHP cancers have been reported since 
1995, most of these are case reports or case series. Further re-
search into long-term follow-up studies is necessary.
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